Category Biochemicals(0) Bioinformatics(0) Biological Remediation(0) Biomedical Engineering(0) Biotechnology Institutions(0) Contract Research Organizations(0) Equipment and Supplies(0) Gene Therapy(0) Medical Equipment(0) Microbiology(0) Pharmaceuticals(0) Proteomics(0) Technology Transfer(0) Tissue Engineering(0) Related News Items New York Biotechnology Association to Honor Regeneron Founders as Business Leaders of the Year Fri, 18 May 2012 05:45:00 -0700 New York Biotechnology Association , the voice of New York State’s bioscience industry, today announced that the 2012 honorees of the Association’s annual leadership awards will be the leaders of Regeneron Pharmaceuticals, New York’s largest biotechnology company: Dr. Read More... Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN® in Combination with the Redox Modulating Agent Motexafin ... Thu, 17 May 2012 04:00:00 -0700 Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN® Injection for intravenous use + rituximab in combination with motexafin gadolinium in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin ... Read More... EnVivo Pharmaceuticals Names Christopher L. Burnley Chief Business Officer Thu, 19 Apr 2012 05:30:00 -0700 EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system therapies, today announced that Christopher L. Burnley has been appointed chief business officer. Read More... Infinity Added to NASDAQ Biotechnology Index Tue, 15 May 2012 05:00:00 -0700 Infinity Pharmaceuticals, Inc. today announced that the company will be added to the NASDAQ Biotechnology Index® . The semi-annual re-ranking of the index will Read More... Panel of Top Industry Executives to Discuss Biotech and Big Pharma – What’s Next? – 2012 BIO International Convention ... Wed, 16 May 2012 13:54:00 -0700 The Biotechnology Industry Organization announced today that a panel of top industry executives will discuss where biotech will be in the next ten years and how the pharmaceutical industry landscape is changing. Read More... Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference Tue, 08 May 2012 04:00:00 -0700 Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the Bank of America Merrill Lynch 2012 Health Care Conference being held at Encore at the Wynn Hotel in Las Vegas, Nevada. Read More... Avraham Pharmaceuticals Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI Thu, 17 May 2012 08:36:00 -0700 Avraham Pharmaceuticals Ltd. announced today the commencement of a Phase 2 clinical trial to evaluate the safety and efficacy of ladostigil in patients diagnosed with mild cognitive impairment . Read More... Spectrum Pharmaceuticals to Present at the Deutsche Bank 37th Annual Health Care Conference Tue, 01 May 2012 04:00:00 -0700 Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the 37th Annual Deutsche Bank Health Care Conference being held at The InterContinental Boston in Boston, Massachusetts. Read More... Spectrum Pharmaceuticals to Be Added to the S&P SmallCap 600 Index Thu, 19 Apr 2012 04:00:00 -0700 Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the company has been selected to be added to the S&P SmallCap 600® Index at the close of trading on Tuesday, April 24, 2012. Read More... Press Release Fri, 18 May 2012 06:09:25 -0700 New York Biotechnology Association (NYBA), the voice of New York State’s bioscience industry, today announced that the 2012 honorees of the Association’s annual leadership awards will be the leaders of Regeneron Pharmaceuticals, New York’s largest biotechnology company: Dr. Leonard Schleifer, MD, PhD, founder, president and CEO, and Dr. George Yancopoulos, MD, PhD, founding scientist ... Read More...

Home | Submit link | New Sites | Top Sites | About

Copyright 2008 , All rights reserved. - Powered by: phpLD - Sponsored by: AllinfoDir Web Directory & Elegant Directory